BSE Live
Mar 27, 16:01Prev. Close
628.30
Open Price
625.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 27, 15:43Prev. Close
627.35
Open Price
623.80
Bid Price (Qty.)
606.95 (2026)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sudeep Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 8.82 | 9.04 | 476.69 | |
| Diluted EPS (Rs.) | 8.82 | 9.04 | 476.69 | |
| Cash EPS (Rs.) | 10.48 | 732.57 | 510.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 44.01 | 2,374.56 | 1,681.07 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 44.01 | 2,374.56 | 1,681.07 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 36.69 | 2,439.56 | 2,867.05 | |
| PBDIT/Share (Rs.) | 14.43 | 996.55 | 705.72 | |
| PBIT/Share (Rs.) | 13.80 | 960.01 | 671.45 | |
| PBT/Share (Rs.) | 13.31 | 938.95 | 644.18 | |
| Net Profit/Share (Rs.) | 9.85 | 696.04 | 476.69 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 39.33 | 40.84 | 24.61 | |
| PBIT Margin (%) | 37.62 | 39.35 | 23.41 | |
| PBT Margin (%) | 36.27 | 38.48 | 22.46 | |
| Net Profit Margin (%) | 26.84 | 28.53 | 16.62 | |
| Return on Networth / Equity (%) | 22.37 | 29.31 | 28.35 | |
| Return on Capital Employed (%) | 28.35 | 39.08 | 37.49 | |
| Return on Assets (%) | 15.84 | 21.76 | 16.14 | |
| Total Debt/Equity (X) | 0.27 | 0.17 | 0.29 | |
| Asset Turnover Ratio (%) | 0.68 | 0.79 | 1.08 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 2.39 | 2.21 | 1.44 | |
| Quick Ratio (X) | 1.90 | 1.77 | 1.12 | |
| Inventory Turnover Ratio (X) | 6.48 | 7.03 | 10.26 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 |
18.02.2026
Sudeep Pharma Consolidated December 2025 Net Sales at Rs 172.34 crore, up 49.16% Y-o-Y
22.12.2025
28.11.2025
28.11.2025